Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Doxycycline in lymphangioleiomyomatosis: not all questions are answered.

Johnson SR, Chang WY, Tattersfield AE, Lewis S, Kumaran M, Cane JL.

Eur Respir J. 2014 May;43(5):1538. doi: 10.1183/09031936.00025014. No abstract available.

2.

A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis.

Chang WY, Cane JL, Kumaran M, Lewis S, Tattersfield AE, Johnson SR.

Eur Respir J. 2014 Apr;43(4):1114-23. doi: 10.1183/09031936.00167413. Epub 2013 Dec 5.

3.

Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, Gray B, Geiling S, Telford H, Tattersfield AE, Hubbard RB, Johnson SR.

QJM. 2011 Nov;104(11):971-9. doi: 10.1093/qjmed/hcr116. Epub 2011 Jul 15.

PMID:
21764810
4.

Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial.

Davies DM, de Vries PJ, Johnson SR, McCartney DL, Cox JA, Serra AL, Watson PC, Howe CJ, Doyle T, Pointon K, Cross JJ, Tattersfield AE, Kingswood JC, Sampson JR.

Clin Cancer Res. 2011 Jun 15;17(12):4071-81. doi: 10.1158/1078-0432.CCR-11-0445. Epub 2011 Apr 27.

5.

Is postmenopausal HRT a risk factor for adult-onset asthma?

Tattersfield AE.

Thorax. 2010 Apr;65(4):282-4. doi: 10.1136/thx.2009.129205. No abstract available.

PMID:
20388749
6.

Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Oborne J, Mortimer K, Hubbard RB, Tattersfield AE, Harrison TW.

Am J Respir Crit Care Med. 2009 Oct 1;180(7):598-602. doi: 10.1164/rccm.200904-0616OC. Epub 2009 Jul 9.

PMID:
19590019
7.

Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.

Whale CI, Sovani MP, Mortimer KJ, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2008 Jun;65(6):841-7. doi: 10.1111/j.1365-2125.2007.03081.x. Epub 2008 Apr 3.

8.

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?

Sovani MP, Whale CI, Oborne J, Cooper S, Mortimer K, Ekström T, Tattersfield AE, Harrison TW.

Br J Gen Pract. 2008 Jan;58(546):37-43. doi: 10.3399/bjgp08X263802.

9.

Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.

Davies DM, Johnson SR, Tattersfield AE, Kingswood JC, Cox JA, McCartney DL, Doyle T, Elmslie F, Saggar A, de Vries PJ, Sampson JR.

N Engl J Med. 2008 Jan 10;358(2):200-3. doi: 10.1056/NEJMc072500. No abstract available.

PMID:
18184971
10.

Advances in respiratory medicine.

Tattersfield AE.

Clin Med (Lond). 2007 Oct;7(5):442-5. No abstract available.

11.

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Mortimer KJ, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW.

Br J Clin Pharmacol. 2007 Oct;64(4):439-44. Epub 2007 Aug 15.

12.

Current issues with beta2-adrenoceptor agonists: historical background.

Tattersfield AE.

Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):107-18.

PMID:
17085787
13.

Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.

Mortimer KJ, Harrison TW, Tang Y, Wu K, Lewis S, Sahasranaman S, Hochhaus G, Tattersfield AE.

Br J Clin Pharmacol. 2006 Oct;62(4):412-9.

14.

Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.

Whale CI, Sovani MP, Mortimer K, Oborne J, Cooper S, Harrison TW, Tattersfield AE.

Br J Clin Pharmacol. 2006 Aug;62(2):153-7.

15.

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

Mortimer KJ, Tata LJ, Smith CJ, West J, Harrison TW, Tattersfield AE, Hubbard RB.

Thorax. 2006 May;61(5):405-8. Epub 2006 Mar 3.

16.

beta-Adrenoceptor polymorphisms: focus moves to long-acting beta-agonists.

Tattersfield AE, Harrison TW.

Am J Respir Crit Care Med. 2006 Mar 1;173(5):473-4. No abstract available.

PMID:
16493161
17.

Lymphangioleiomyomatosis: a national registry for a rare disease.

Tattersfield AE, Glassberg MK.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):2-4. No abstract available.

PMID:
16368790
18.

When should a long acting {beta} agonist be added to an inhaled corticosteroid?

Tattersfield AE.

Thorax. 2005 Sep;60(9):710. No abstract available.

19.

Safety of inhaled corticosteroids.

Tattersfield AE, Harrison TW, Hubbard RB, Mortimer K.

Proc Am Thorac Soc. 2004;1(3):171-5. Review.

PMID:
16113431
20.

Lymphangioleiomyomatosis.

Johnson SR, Tattersfield AE.

Semin Respir Crit Care Med. 2002 Apr;23(2):85-92.

PMID:
16088601
21.

Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.

Mortimer KJ, Tattersfield AE.

Immunol Allergy Clin North Am. 2005 Aug;25(3):523-39. Review.

PMID:
16054541
22.

Use of upper limb exercise to assess breathlessness in patients with cancer: tolerability, repeatability, and sensitivity.

Wilcock A, Walker G, Manderson C, Carr D, Broadhurst D, Crosby V, Pavis H, Edgecombe J, Tattersfield AE.

J Pain Symptom Manage. 2005 Jun;29(6):559-64.

PMID:
15963864
23.

Effects of inhaled corticosteroids on bone.

Mortimer KJ, Harrison TW, Tattersfield AE.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):15-21; quiz 22-3, 79. Review.

PMID:
15702810
24.

Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. 1983.

Cushley MJ, Tattersfield AE, Holgate ST.

Br J Clin Pharmacol. 2004 Dec;58(7):S751-5; discussion S756-8. No abstract available.

25.

Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story.

Tattersfield AE, Hall IP.

Lancet. 2004 Oct 23-29;364(9444):1464-6. No abstract available.

PMID:
15500871
26.

A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.

Sovani MP, Whale CI, Tattersfield AE.

Drug Saf. 2004;27(10):689-715. Review.

PMID:
15350154
27.

Survival and disease progression in UK patients with lymphangioleiomyomatosis.

Johnson SR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE.

Thorax. 2004 Sep;59(9):800-3.

28.

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.

Harrison TW, Oborne J, Newton S, Tattersfield AE.

Lancet. 2004 Jan 24;363(9405):271-5.

PMID:
14751699
29.

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):26-30.

30.

Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma.

Phillips K, Oborne J, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):21-5.

31.

Lymphangioleiomyomatosis: a case-control study of perinatal and early life events.

Whale CI, Johnson SR, Phillips KG, Newton SA, Lewis SA, Tattersfield AE.

Thorax. 2003 Nov;58(11):979-82.

32.

Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids.

Ståhl E, Postma DS, Svensson K, Tattersfield AE, Eivindson A, Schreurs A, Löfdahl CG.

Respir Med. 2003 Sep;97(9):1061-6.

33.

Measuring inspiratory muscle weakness in patients with cancer and breathlessness.

Feathers LS, Wilcock A, Manderson C, Weller R, Tattersfield AE.

J Pain Symptom Manage. 2003 Apr;25(4):305-6. No abstract available.

PMID:
12691681
34.

Low-dose budesonide for asthma.

Tattersfield AE, Harrison TW.

Lancet. 2003 Mar 29;361(9363):1066-7. No abstract available. Erratum in: Lancet. 2003 Jun 7;361(9373):1994.

PMID:
12672304
35.

Systemic effects of inhaled corticosteroids.

Harrison TW, Tattersfield AE.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):1037-8; author reply 1038. No abstract available.

PMID:
12663345
37.

Asthma.

Tattersfield AE, Knox AJ, Britton JR, Hall IP.

Lancet. 2002 Oct 26;360(9342):1313-22. Review.

PMID:
12414223
38.

Inhaled corticosteroids and hip fracture: a population-based case-control study.

Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE.

Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1563-6. Epub 2002 Sep 25.

PMID:
12406825
39.

The impact of oral corticosteroid use on bone mineral density and vertebral fracture.

Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, Harrison T, Green DJ, Pringle M, Hubbard R, Tattersfield AE.

Am J Respir Crit Care Med. 2002 Sep 1;166(5):691-5.

PMID:
12204867
40.

The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.

Johnson SR, Clelland CA, Ronan J, Tattersfield AE, Knox AJ.

Histopathology. 2002 May;40(5):458-63.

PMID:
12010366
41.

Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases.

Wilcock A, Crosby V, Hughes A, Fielding K, Corcoran R, Tattersfield AE.

J Pain Symptom Manage. 2002 Mar;23(3):182-9.

PMID:
11888716
42.

Exacerbations of asthma--still room for improvement.

Tattersfield AE, Harrison TW.

Lancet. 2001 Aug 25;358(9282):599-601. No abstract available.

PMID:
11530142
43.

Inhaled steroids for COPD?

Tattersfield AE, Harrison TW.

Thorax. 2001 Sep;56 Suppl 2:ii2-6. Review. No abstract available.

44.

Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study.

Andersson F, Stahl E, Barnes PJ, Löfdahl CG, O'Byrne PM, Pauwels RA, Postma DS, Tattersfield AE, Ullman A; Formoterol and Corticosteroid Establishing Therapy. International Study Group.

Respir Med. 2001 Jun;95(6):505-12.

45.

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.

Walsh LJ, Wong CA, Oborne J, Cooper S, Lewis SA, Pringle M, Hubbard R, Tattersfield AE.

Thorax. 2001 Apr;56(4):279-84.

46.

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.

Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R.

Thorax. 2001 Apr;56(4):272-8.

47.

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.

Tattersfield AE, Löfdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, Ekström T.

Lancet. 2001 Jan 27;357(9252):257-61.

PMID:
11214127
48.
49.

Clinical experience of lymphangioleiomyomatosis in the UK.

Johnson SR, Tattersfield AE.

Thorax. 2000 Dec;55(12):1052-7.

50.

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.

Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE.

Thorax. 2000 Aug;55(8):650-6.

Supplemental Content

Loading ...
Support Center